BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29313653)

  • 21. Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis?
    Starnes SL; Reed MF; Meyer CA; Shipley RT; Jazieh AR; Pina EM; Redmond K; Huffman LC; Pandalai PK; Howington JA
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):688-93. PubMed ID: 20933243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds.
    Henschke CI; Yip R; Smith JP; Wolf AS; Flores RM; Liang M; Salvatore MM; Liu Y; Xu DM; Yankelevitz DF;
    AJR Am J Roentgenol; 2016 Dec; 207(6):1176-1184. PubMed ID: 27726410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pack-Year Cigarette Smoking History for Determination of Lung Cancer Screening Eligibility. Comparison of the Electronic Medical Record versus a Shared Decision-making Conversation.
    Modin HE; Fathi JT; Gilbert CR; Wilshire CL; Wilson AK; Aye RW; Farivar AS; Louie BE; Vallières E; Gorden JA
    Ann Am Thorac Soc; 2017 Aug; 14(8):1320-1325. PubMed ID: 28406708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a Lung Cancer Screening Counseling and Shared Decision-Making Visit.
    Mazzone PJ; Tenenbaum A; Seeley M; Petersen H; Lyon C; Han X; Wang XF
    Chest; 2017 Mar; 151(3):572-578. PubMed ID: 27815154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Nodules: Common Questions and Answers.
    Langan RC; Goodbred AJ
    Am Fam Physician; 2023 Mar; 107(3):282-291. PubMed ID: 36920823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for lung cancer.
    Midthun DE
    Clin Chest Med; 2011 Dec; 32(4):659-68. PubMed ID: 22054878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
    Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
    Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computed Tomography Scanning for Early Detection of Lung Cancer.
    Jacobson FL; Jaklitsch MT
    Annu Rev Med; 2018 Jan; 69():235-245. PubMed ID: 29414260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung Cancer Screening.
    Choi HK; Mazzone PJ
    Med Clin North Am; 2022 Nov; 106(6):1041-1053. PubMed ID: 36280331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The United States Preventive Services Task Force recommendations for lung cancer screening.
    Blackmon SH; Feinglass SR
    Thorac Surg Clin; 2015 May; 25(2):199-203. PubMed ID: 25901563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Dose CT Scan for Lung Cancer Screening: Clinical and Coding Considerations.
    Shieh Y; Bohnenkamp M
    Chest; 2017 Jul; 152(1):204-209. PubMed ID: 28336485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung cancer screening: latest developments and unanswered questions.
    van der Aalst CM; Ten Haaf K; de Koning HJ
    Lancet Respir Med; 2016 Sep; 4(9):749-761. PubMed ID: 27599248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare.
    Roth JA; Sullivan SD; Goulart BH; Ravelo A; Sanderson JC; Ramsey SD
    J Oncol Pract; 2015 Jul; 11(4):267-72. PubMed ID: 25943596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography in the diagnostic work-up of screening-detected lung nodules.
    Veronesi G; Travaini LL; Maisonneuve P; Rampinelli C; Bertolotti R; Spaggiari L; Bellomi M; Paganelli G
    Eur Respir J; 2015 Feb; 45(2):501-10. PubMed ID: 25261326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Issues in the Surgical Management of Screen-Identified Lung Cancers.
    Kamel M; Stiles B; Altorki NK
    Oncology (Williston Park); 2015 Dec; 29(12):944-9, 951. PubMed ID: 26676898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule.
    Brawley OW; Flenaugh EL
    Oncology (Williston Park); 2014 May; 28(5):441-6. PubMed ID: 25004661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Solitary Pulmonary Nodule.
    Harzheim D; Eberhardt R; Hoffmann H; Herth FJ
    Respiration; 2015; 90(2):160-72. PubMed ID: 26138915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Krist AH; Davidson KW; Mangione CM; Barry MJ; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Kubik M; Landefeld CS; Li L; Ogedegbe G; Owens DK; Pbert L; Silverstein M; Stevermer J; Tseng CW; Wong JB
    JAMA; 2021 Mar; 325(10):962-970. PubMed ID: 33687470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians.
    Ersek JL; Eberth JM; McDonnell KK; Strayer SM; Sercy E; Cartmell KB; Friedman DB
    Cancer; 2016 Aug; 122(15):2324-31. PubMed ID: 27294476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.